Skip to main content

Advertisement

Log in

Progress and recent trends in photodynamic therapy with nanoparticles

  • Review
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Background

Photodynamic therapy (PDT) is an emerging treatment option for various therapeutic areas owing to its outstanding advantages compared with conventional therapies. PDT consists of three main components; a photosensitizer, a proper wavelength of light and oxygen. This alternative treatment is based on the selective accumulation of photosensitizers which generate reactive oxygen species to induce cell apoptosis and necrosis under the light irradiation. PDT provides less invasive way with high therapeutic efficacy and reduced side effects. When PDT is combined with nanoplatform, drug loading efficacy, tissue targeting efficiency and accumulation rate were enhanced leading to increase the therapeutic effect of PDT.

Area covered

In this review, we described progress and recent trends in nanoplatform-based PDT in various cancers and infectious diseases. We have selected lung cancer, liver cancer, and breast cancer for representative cancer types furthermore, bacteria-infected wound and acne vulgaris for typical infectious diseases. The above therapeutic areas were chosen since the researches on PDT with nanoparticles are actively ongoing with these indications. PDT as well as PDT with chemotherapy, and PDT with immunotherapy strategies were covered in this review.

Expert opinion

Nanotechnology combined with PDT greatly improved the therapeutic efficacy compared with PDT alone. In addition, novel combination strategies effectively enhanced the therapeutic outcomes with reduced side effects. However, more safety data will be needed to lead these innovative strategies to the clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

[Reprinted with permission from ACS publications (Song et al. 2018).]

Fig. 2
Fig. 3

[Reprinted with permission from John Wiley and Sons publications (Hu et al. 2021).]

Fig. 4

[Reprinted with permission from John Wiley and Sons publications (Gao et al. 2018).]

Similar content being viewed by others

References

Download references

Acknowledgements

This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government (MSIT) (No. 2022R1F1A1065569).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ji-Eun Chang.

Ethics declarations

Conflict of interest

All authors (K. Rhew, Y.J. Chae, and J.E. Chang) declare that they have no confict of interest.

Research involving human and animal rights

This article does not contain any studies with human and animal subjects performed by any of the authors of this publication.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rhew, K., Chae, YJ. & Chang, JE. Progress and recent trends in photodynamic therapy with nanoparticles. J. Pharm. Investig. 52, 587–599 (2022). https://doi.org/10.1007/s40005-022-00594-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-022-00594-8

Keywords

Navigation